VANECK PHARMACEUTICAL ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.57 EUR | -0.22% |
|
-0.59% | +16.93% |
Composition of VanEck Pharmaceutical ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
|---|---|---|---|---|---|---|
| 905.4 USD | -0.40% | +2.43% | +55.32% | 11.58% | ||
| 146.2 USD | +0.25% | -1.74% | -6.75% | 6.43% | ||
| 123.8 USD | -4.64% | -5.29% | +13.56% | 6.38% | ||
| 171.5 USD | +1.50% | +0.66% | +10.68% | 5.59% | ||
| 225.3 USD | -1.17% | -4.81% | +9.70% | 4.73% | ||
| 584 USD | -1.54% | -3.16% | +26.15% | 4.72% | ||
| 27.98 USD | +0.65% | +0.87% | -2.81% | 4.36% | ||
| 173.4 USD | -1.76% | +1.33% | -12.16% | 4.02% | ||
| 41.53 USD | +0.05% | -0.95% | -19.06% | 3.87% | ||
| 16.25 USD | -0.06% | -4.19% | +55.65% | 2.90% | ||
| 10.63 USD | +1.43% | +1.53% | -1.85% | 1.89% | ||
| 106.7 USD | -0.35% | -1.15% | -13.23% | 1.04% | ||
| 56.23 USD | -0.32% | -0.48% | +25.15% | 0.96% | ||
| 14.43 USD | +1.12% | -20.06% | -3.15% | 0.81% | ||
| 25.68 USD | +0.98% | -0.39% | -20.20% | 0.68% | ||
| 20.7 USD | +0.53% | -0.67% | +43.55% | 0.61% | ||
| 6.97 USD | +1.16% | +2.50% | -13.09% | 0.48% | ||
| 24.12 USD | +1.47% | -0.78% | -15.22% | 0.31% | ||
ETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | Actions |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Fund Structure | |
| Replication Model | |
| Date of creation |
19/12/2011
|
| Geographical Focus |
AuM evolution ( 30/05/2024 )
| AuM (EUR) | 524 M€ |
|---|---|
| AuM 1M | 479 M€ |
| AuM 3 months | 475 M€ |
| AuM 6 months | 365 M€ |
| AuM 12 months | 358 M€ |
- Stock Market
- ETF
- VEFV ETF
- Components VanEck Pharmaceutical ETF - USD
